| http://www.w3.org/ns/prov#value | - Time to market is a critical factor for leading pharmaceutical companies, and Medidata RAVE provides BHC with the opportunity to increase clinical trial capacity through optimal use of resources, while simultaneously lowering overall R&D costs. said Glen de Vries, CTO Medidata Solutions.
|
